Evolus
(NASDAQ) EOLS
Evolus Financials at a Glance
Market Cap
$301.23M
Revenue (TTM)
$297.18M
Net Income (TTM)
$51.64M
EPS (TTM)
$-0.80
P/E Ratio
-5.76
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$4.53
Volume
322,503.705
Open
$4.56
Price
$4.53
Volume
322,503.705
Open
$4.56
Previous Close
$4.53
Daily Range
$4.50 - $4.62
52-Week Range
$3.86 - $12.28
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$4.53
Volume
322,503.705
Open
$4.56
Previous Close
$4.53
Daily Range
$4.50 - $4.62
52-Week Range
$3.86 - $12.28
EOLS News
Why Evolus Stock Soared Today
Why Evolus Shares Jumped This Week
EOLS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evolus
Industry
Pharmaceuticals
Sector
Health CareEmployees
334
CEO
David Moatazedi, MBA
Website
www.evolus.comHeadquarters
Newport Beach, CA 92660, US
EOLS Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
-13%
Net Income Margin
-17%
Return on Equity
-18730%
Return on Capital
-25%
Return on Assets
-23%
Earnings Yield
-17.36%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$301.23M
Shares Outstanding
65.06M
Volume
322.50K
Short Interest
0.00%
Avg. Volume
1.15M
Financials (TTM)
Gross Profit
$192.76M
Operating Income
$37.60M
EBITDA
$28.86M
Operating Cash Flow
$42.27M
Capital Expenditure
$3.44M
Free Cash Flow
$45.71M
Cash & ST Invst.
$53.83M
Total Debt
$155.00M
Evolus Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$90.30M
+14.4%
Gross Profit
$57.84M
+14.9%
Gross Margin
64.06%
N/A
Market Cap
$301.23M
N/A
Market Cap/Employee
$809.75K
N/A
Employees
372
N/A
Net Income
$130.00K
+101.9%
EBITDA
$2.30M
+267.8%
Quarterly Fundamentals
Net Cash
$101.17M
-135.1%
Accounts Receivable
$54.70M
+14.7%
Inventory
$26.96M
+121.8%
Long Term Debt
$152.47M
+18.9%
Short Term Debt
$2.53M
+47.2%
Return on Assets
-22.86%
N/A
Return on Invested Capital
-24.69%
N/A
Free Cash Flow
$11.35M
+229.3%
Operating Cash Flow
$12.83M
+166.8%